A 77-year-old Vermont man was killed on Sunday afternoon while attempting to rescue a turtle on Interstate 95 in Indian River ...

DEAR MISS MANNERS: I am a gentleman who strives to live a mannerly life. In that regard, when riding public transportation, I ...

There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...

Maria Pasqual was a flower farmer in Maili, loved by those who encountered her. The family who lives next door to her farm ...

Many in the MAGA movement are in a state of anger and disbelief over the Justice Department and FBI’s memo disclosing that ...

The suspect told the victim to “shut up,'' sparking a dispute in which she became "aggressive'' and he walloped her multiple ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips.

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...